Just wrapped a great conversation with @CEOMagazineGL 🎙️ We covered the major shift happening in healthcare, why personalized medicine matters, the role compounding plays in giving patients and providers more options, and what it has taken to scale @strivepharmacy
Modern medicine is undergoing a massive shift. What works for one patient might not work for another, and scaling a business during this time adds to the challenge.
During MOTS-C hearing: “Two of the three that were just against this happen to be publicly affiliated with Lilly and Novo. I wonder why they’re against a peptide that helps people lose weight and get in shape? Probably some thoughts about that one…”
—@LeeRosebush got that DAWG in him! 🔥
Today our industry showed up big at the FDA’a PCAC hearing on peptides. A win for personalized medicine isn’t one company’s win. It’s providers, pharmacists, and advocates in the same room, pushing for one thing: patients deserve regulated access.
Compounding is not a crime.
🚨 THE $HIMS HOUSE PODCAST IS BACK!!!
We're chatting with Strive's CEO & CMO (@gonatehill@ZachShurtleff) on Friday. Episode drops Monday.
Strive just dropped a bombshell lawsuit vs. $LLY and $NVO for suppressing competition and limiting patient access to compounded GLP-1s.
If you have questions you'd like me to Nate and Zach, drop them below!
$HIMS $LLY $NVO
🚨 BREAKING: STRIVE SUES ELI LILLY & NOVO NORDISK FOR VIOLATING THE SHERMAN ANTI-TRUST ACT
- Strive alleges that Lilly and Novo illegally monopolized the GLP-1 drug market
- Claims both companies forced telehealth providers into exclusive agreements prohibiting them from working with compounding pharmacies
- Claims Lilly smeared compounded GLP-1s as "never safe" and "always illegal" despite compounding being federally authorized; and sought to interfere with Strive's relationships with payment processors and social media platforms
- Hims mentioned 10 times
- Ro, LifeMD, Noom, and Weight Watchers mentioned as well
Strive is seeking declaratory judgment, permanent injunctive relief, treble damages, costs and attorneys' fees, and any additional relief necessary to restore competitive conditions in the GLP-1 market
Healthcare has lost sight of health and care. Strive was born from a mission to put people back at the center of wellness and constantly improve medicine, patient care, and personal possibilities on every level.
Proud to keep up the fight involving patient and provider access to personalized medicine and compounding pharmacy with the team at Strive. Keep fighting the good fight
@strivepharmacy@gonatehill
@zshurtleff